Remmie, Inc., a medical technology company announced today that they received a Phase I SBIR award from the National Institutes of Health’s National Institute on Deafness and Other Communications Disorders (NIDCD). With Remmie’s proposed Remmie.ai method, the suite of digital at-home connected otoscope will leverage cloud service and API interface for clinicians to not only have a clear view remotely, but also receive assistance, in-person or remotely, in making clinical decisions on ENT conditions, powered by a deep learning AI/ML engine.
Remmie, Inc., a medical technology company announced today that they received a Phase I SBIR award from the National Institutes of Health’s National Institute on Deafness and Other Communications Disorders (NIDCD). With Remmie’s proposed Remmie.ai method, the suite of digital at-home connected otoscope will leverage cloud service and API interface for clinicians to not only have a clear view remotely, but also receive assistance, in-person or remotely, in making clinical decisions on ENT conditions, powered by a deep learning AI/ML engine.
Alia Levi, Content Marketing Specialist Remmie Health pr@remmiehealth.com https://remmiehealth.com [Seattle, WA, June 14, 2021] Remmi...
[Seattle, WA, May 10th, 2021] Remmie Health, a Seattle-based healthcare technology company that builds remote solutions for ear-nose-throat home...
